HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Malcolm A S Moore Selected Research

IMC1C11

11/2004Targeting autocrine and paracrine VEGF receptor pathways inhibits human lymphoma xenografts in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Malcolm A S Moore Research Topics

Disease

22Neoplasms (Cancer)
01/2021 - 06/2003
9Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2015 - 01/2004
6Leukemia
11/2015 - 12/2003
6Multiple Myeloma
08/2012 - 06/2003
5Neoplasm Metastasis (Metastasis)
01/2021 - 03/2010
4Osteosarcoma (Osteogenic Sarcoma)
01/2021 - 01/2014
4Lymphoma (Lymphomas)
11/2004 - 06/2003
2Sarcoma (Soft Tissue Sarcoma)
01/2021 - 07/2016
2Ewing Sarcoma (Sarcoma, Ewing)
07/2016 - 03/2014
2Necrosis
09/2015 - 01/2014
2Malignant Mesothelioma
01/2014 - 07/2012
2Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
08/2013 - 08/2012
2Genetic Translocation (Chromosomal Translocation)
05/2011 - 09/2004
2Non-Hodgkin Lymphoma (Lymphosarcoma)
11/2004 - 01/2004
2Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
09/2004 - 12/2003
1Giant Cell Tumor of Tendon Sheath
01/2021
1Fibrosarcoma
01/2021
1Rhabdomyosarcoma
07/2016
1Neutropenia
10/2015
1Fibrosis (Cirrhosis)
09/2015
1Peritoneal Neoplasms
11/2014
1Ovarian Neoplasms (Ovarian Cancer)
11/2014
1Carcinoma (Carcinomatosis)
11/2014
1Autosomal Recessive 3 Severe Congenital Neutropenia
04/2014
1Mesothelioma
04/2014
1Polycythemia (Erythrocytosis)
08/2012
1Adenocarcinoma of Lung
07/2012
1Lung Neoplasms (Lung Cancer)
09/2011
1Blister (Bulla)
05/2009
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
12/2006
1Body Weight (Weight, Body)
07/2005

Drug/Important Bio-Agent (IBA)

7Proteins (Proteins, Gene)FDA Link
11/2015 - 12/2003
4Pharmaceutical PreparationsIBA
11/2015 - 07/2005
4Telomerase (Telomerase Reverse Transcriptase)IBA
01/2005 - 06/2003
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2014 - 11/2004
3Bortezomib (Velcade)FDA Link
04/2014 - 08/2012
3Methotrexate (Mexate)FDA LinkGeneric
11/2004 - 06/2003
2CytokinesIBA
01/2021 - 03/2004
2Messenger RNA (mRNA)IBA
01/2016 - 03/2004
2palbociclibIBA
05/2015 - 08/2006
2Cytarabine (Cytosar-U)FDA LinkGeneric
05/2015 - 09/2004
2Transcription Factors (Transcription Factor)IBA
04/2014 - 03/2004
2Imatinib Mesylate (Gleevec)FDA Link
08/2013 - 08/2012
2Cyclin-Dependent Kinase 4IBA
08/2012 - 08/2006
2migrastatinIBA
09/2011 - 03/2010
2Ether (Diethyl Ether)IBA
09/2011 - 03/2010
2nuclear pore complex protein 98IBA
05/2011 - 12/2006
2Complementary DNA (cDNA)IBA
03/2004 - 03/2004
1pexidartinibIBA
01/2021
1Conditioned Culture MediaIBA
01/2021
16-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA
01/2019
11- (3- ((2- (dimethylamino)ethyl)carbamoyl)phenyl)- 3- (4- (bis(2- chloroethyl)amino)phenyl)ureaIBA
07/2016
1Irinotecan (Camptosar)FDA LinkGeneric
07/2016
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
07/2016
1DNA (Deoxyribonucleic Acid)IBA
07/2016
1Drug CombinationsIBA
07/2016
1Biomarkers (Surrogate Marker)IBA
01/2016
1Histone MethyltransferasesIBA
01/2016
1Adenosine Triphosphate (ATP)IBA
11/2015
1Excipients (Suspending Agents)IBA
11/2015
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
11/2015
1AICA ribonucleotide (ZMP)IBA
11/2015
1LenograstimIBA
10/2015
1Filgrastim (Neupogen)FDA Link
10/2015
1AlkaloidsIBA
09/2015
1Arecoline (Arecolin)IBA
09/2015
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
09/2015
1Cholinergic Agents (Cholinergics)IBA
09/2015
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
09/2015
1Cyclin-Dependent Kinases (cdk Proteins)IBA
05/2015
1A-factor (Streptomyces)IBA
11/2014
1Monoclonal AntibodiesIBA
11/2014
1Bevacizumab (Avastin)FDA Link
11/2014
1Lymphoid Enhancer-Binding Factor 1IBA
04/2014
1Granulocyte Colony-Stimulating Factor Receptors (G-CSF Receptor)IBA
04/2014
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
04/2014
1STAT5 Transcription FactorIBA
04/2014
1LipidsIBA
04/2014
1Trinitrotoluene (TNT)IBA
04/2014
1Proteasome InhibitorsIBA
03/2014
16- amino- 8- ((6- iodo- 1,3- benzodioxol- 5- yl)thio)- N- (1- methylethyl)- 9H-purine-9-propanamineIBA
03/2014
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
01/2014
1Biological ProductsIBA
09/2011
1Cantharidin (Cantharides)IBA
05/2009
1LuciferasesIBA
03/2007
1IGF Type 1 Receptor (IGF 1 Receptor)IBA
03/2007
1Insulin-Like Growth Factor I (IGF-1)IBA
03/2007
1Cyclin-Dependent Kinase Inhibitor p16IBA
11/2006
1Epothilones (Epothilone)IBA
07/2005
1fludeloneIBA
07/2005
126- trifluoro- (E)- 9,10- dehydro- 12,13- desoxyepothilone BIBA
07/2005
1desoxyepothilone B (epothilone D)IBA
07/2005
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
11/2004
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
11/2004
1AntibodiesIBA
11/2004
1Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
11/2004

Therapy/Procedure

13Therapeutics
05/2015 - 06/2003
4Drug Therapy (Chemotherapy)
07/2016 - 09/2004
3Transplantation
09/2004 - 10/2003
1Immunotherapy
01/2021